EXEL
Exelixis Inc
Price:  
34.49 
USD
Volume:  
3,535,564.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXEL EV/EBITDA

-20.5%
Upside

As of 2025-02-14, the EV/EBITDA ratio of Exelixis Inc (EXEL) is 15.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EXEL's latest enterprise value is 9,591.31 mil USD. EXEL's TTM EBITDA according to its financial statements is 635.41 mil USD. Dividing these 2 quantities gives us the above EXEL EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 15.2x - 16.1x 15.6x
Forward P/E multiples 19.0x - 25.9x 22.1x
Fair Price 16.74 - 36.64 27.42
Upside -51.5% - 6.2% -20.5%
34.49 USD
Stock Price
27.42 USD
Fair Price

EXEL EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-13 15.09
2025-02-12 14.34
2025-02-11 14.34
2025-02-10 14.65
2025-02-07 14.64
2025-02-06 14.73
2025-02-05 14.67
2025-02-04 14.48
2025-02-03 14.37
2025-01-31 14.49
2025-01-30 14.39
2025-01-29 14.41
2025-01-28 14.25
2025-01-27 14.30
2025-01-24 14.15
2025-01-23 14.93
2025-01-22 14.37
2025-01-21 15.97
2025-01-17 15.86
2025-01-16 16.02
2025-01-15 16.34
2025-01-14 15.62
2025-01-13 15.46
2025-01-10 15.78
2025-01-08 15.10
2025-01-07 14.97
2025-01-06 14.51
2025-01-03 14.86
2025-01-02 14.85
2024-12-31 14.56
2024-12-30 14.74
2024-12-27 14.79
2024-12-26 14.89
2024-12-24 14.79
2024-12-23 14.64
2024-12-20 14.56
2024-12-19 14.73
2024-12-18 14.72
2024-12-17 15.18
2024-12-16 15.80
2024-12-13 15.34
2024-12-12 15.40
2024-12-11 15.51
2024-12-10 15.43
2024-12-09 15.40
2024-12-06 15.69
2024-12-05 15.79
2024-12-04 15.67
2024-12-03 15.44
2024-12-02 15.59